• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型姜黄素类似物(顺式-反式姜黄素)作为腺苷受体 A 和 A 的配体:治疗潜力。

Novel curcumin analog (cis-trans curcumin) as ligand to adenosine receptors A and A: potential for therapeutics.

机构信息

Department of Biology, University of Nebraska-Kearney, United States.

Department of Chemistry, University of Nebraska-Kearney, United States.

出版信息

Pharmacol Res. 2021 Mar;165:105410. doi: 10.1016/j.phrs.2020.105410. Epub 2021 Jan 2.

DOI:10.1016/j.phrs.2020.105410
PMID:33401004
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7979524/
Abstract

All four of the adenosine receptor (AR) subtypes mediate pain and have been targeted by pharmacologists to generate new therapeutics for chronic pain. The vanilloid phytochemicals, which include curcumin, capsaicin, and gingerol, have been shown to alleviate pain. However, there is little to no literature on the interaction of vanilloid phytochemicals with ARs. In this study, photochemical methods were used to generate a novel isomer of curcumin (cis-trans curcumin or CTCUR), and the interactions of both curcumin and CTCUR with the two G-linked AR subtypes were studied. Competitive binding assays, docking analysis, and confocal fluorescence microscopy were performed to measure binding affinity; cell survival assays were used to measure toxicity; and cAMP assays were performed to measure receptor activation. Competitive binding results indicated that CTCUR binds to both AR A and AR A with K values of 5 μM and 7 μM, respectively, which is consistent with our docking results. Fluorescence microscopy data also shows binding for A and A. Cell survival results show that CTCUR and CUR are nontoxic at the tested concentrations in these cell lines. Overall, our results suggest that vanilloid phytochemicals may be slightly modified to increase interaction with G-ARs, and thereby can be further explored to provide a novel class of non-opioid antinociceptives.

摘要

所有四种腺苷受体(AR)亚型都介导疼痛,并已被药理学家靶向,以产生用于慢性疼痛的新疗法。香草素植物化学物质,包括姜黄素、辣椒素和姜辣素,已被证明可以缓解疼痛。然而,关于香草素植物化学物质与 AR 的相互作用的文献很少。在这项研究中,光化学方法被用于生成姜黄素的一种新异构体(顺式-反式姜黄素或 CTCUR),并研究了姜黄素和 CTCUR 与两种 G 链接的 AR 亚型的相互作用。竞争性结合测定、对接分析和共聚焦荧光显微镜用于测量结合亲和力;细胞存活测定用于测量毒性;cAMP 测定用于测量受体激活。竞争性结合结果表明,CTCUR 分别以 5 μM 和 7 μM 的 K 值与 AR A 和 AR A 结合,这与我们的对接结果一致。荧光显微镜数据也显示 A 和 A 的结合。细胞存活结果表明,在这些细胞系中,CTCUR 和 CUR 在测试浓度下均无毒性。总的来说,我们的结果表明,香草素植物化学物质可能经过轻微修饰以增加与 G-AR 的相互作用,因此可以进一步探索以提供一类新型非阿片类镇痛药。

相似文献

1
Novel curcumin analog (cis-trans curcumin) as ligand to adenosine receptors A and A: potential for therapeutics.新型姜黄素类似物(顺式-反式姜黄素)作为腺苷受体 A 和 A 的配体:治疗潜力。
Pharmacol Res. 2021 Mar;165:105410. doi: 10.1016/j.phrs.2020.105410. Epub 2021 Jan 2.
2
Curcumin Stereoisomer, Cis-Trans Curcumin, as a Novel Ligand to A and A Adenosine Receptors.姜黄素立体异构体,顺反式姜黄素,作为A和A腺苷受体的新型配体。
Pharmaceuticals (Basel). 2023 Jun 22;16(7):917. doi: 10.3390/ph16070917.
3
Characterisation of endogenous A and A receptor-mediated cyclic AMP responses in HEK 293 cells using the GloSensor™ biosensor: Evidence for an allosteric mechanism of action for the A-selective antagonist PSB 603.使用GloSensor™生物传感器对HEK 293细胞中内源性A和A受体介导的环磷酸腺苷反应进行表征:A选择性拮抗剂PSB 603变构作用机制的证据。
Biochem Pharmacol. 2018 Jan;147:55-66. doi: 10.1016/j.bcp.2017.10.013. Epub 2017 Oct 26.
4
A and A adenosine receptors: The extracellular loop 2 determines high (A) or low affinity (A) for adenosine.A 和 A 腺苷受体:细胞外环 2 决定了对腺苷的高(A)或低亲和力(A)。
Biochem Pharmacol. 2020 Feb;172:113718. doi: 10.1016/j.bcp.2019.113718. Epub 2019 Nov 18.
5
Blood Platelet Adenosine Receptors as Potential Targets for Anti-Platelet Therapy.血小板腺苷受体作为抗血小板治疗的潜在靶点。
Int J Mol Sci. 2019 Nov 3;20(21):5475. doi: 10.3390/ijms20215475.
6
Selectivity is species-dependent: Characterization of standard agonists and antagonists at human, rat, and mouse adenosine receptors.选择性具有物种依赖性:人、大鼠和小鼠腺苷受体上标准激动剂和拮抗剂的特性
Purinergic Signal. 2015 Sep;11(3):389-407. doi: 10.1007/s11302-015-9460-9. Epub 2015 Jul 1.
7
Molecular dynamics simulations reveal insights into key structural elements of adenosine receptors.分子动力学模拟揭示了对腺苷受体关键结构元素的深入了解。
Biochemistry. 2011 May 17;50(19):4194-208. doi: 10.1021/bi200100t. Epub 2011 Apr 20.
8
Molecular modeling of adenosine receptors.腺苷受体的分子建模
Methods Enzymol. 2013;522:37-59. doi: 10.1016/B978-0-12-407865-9.00003-0.
9
Novel fluorescent triazinobenzimidazole derivatives as probes for labelling human A and A adenosine receptor subtypes.新型荧光三嗪苯并咪唑衍生物作为标记人 A 和 A 腺苷受体亚型的探针。
Bioorg Med Chem. 2018 Dec 1;26(22):5885-5895. doi: 10.1016/j.bmc.2018.10.039. Epub 2018 Nov 1.
10
The second extracellular loop of GPCRs determines subtype-selectivity and controls efficacy as evidenced by loop exchange study at A2 adenosine receptors.GPCRs 的第二细胞外环决定了亚型选择性,并通过 A2 腺苷受体的环交换研究证明了其控制效力。
Biochem Pharmacol. 2013 May 1;85(9):1317-29. doi: 10.1016/j.bcp.2013.03.005. Epub 2013 Mar 13.

引用本文的文献

1
Emerging paradigms for target discovery of traditional medicines: A genome-wide pan-GPCR perspective.传统药物靶点发现的新兴模式:全基因组泛G蛋白偶联受体视角
Innovation (Camb). 2025 Jan 17;6(3):100774. doi: 10.1016/j.xinn.2024.100774. eCollection 2025 Mar 3.
2
Enhancing the Bioavailability and Bioactivity of Curcumin for Disease Prevention and Treatment.提高姜黄素的生物利用度和生物活性以预防和治疗疾病。
Antioxidants (Basel). 2024 Mar 8;13(3):331. doi: 10.3390/antiox13030331.
3
Curcumin Stereoisomer, Cis-Trans Curcumin, as a Novel Ligand to A and A Adenosine Receptors.姜黄素立体异构体,顺反式姜黄素,作为A和A腺苷受体的新型配体。
Pharmaceuticals (Basel). 2023 Jun 22;16(7):917. doi: 10.3390/ph16070917.
4
Purinergic signaling: a potential therapeutic target for depression and chronic pain.嘌呤能信号转导:抑郁症和慢性疼痛的潜在治疗靶点。
Purinergic Signal. 2023 Mar;19(1):163-172. doi: 10.1007/s11302-021-09801-x. Epub 2021 Aug 2.

本文引用的文献

1
1,3-Dialkylxanthine Derivatives Having High Potency as Antagonists at Human A Adenosine Receptors.作为人 A 型腺苷受体拮抗剂具有高效能的 1,3 - 二烷基黄嘌呤衍生物。
Drug Dev Res. 1999 May;47(1):45-53. doi: 10.1002/(sici)1098-2299(199905)47:1<45::aid-ddr6>3.0.co;2-u.
2
Polymicrobial Interactions Induce Multidrug Tolerance in Through Energy Depletion.多种微生物相互作用通过能量耗竭诱导多重耐药性。
Front Microbiol. 2019 Dec 5;10:2803. doi: 10.3389/fmicb.2019.02803. eCollection 2019.
3
A Adenosine Receptor and Cancer.腺嘌呤受体与癌症。
Int J Mol Sci. 2019 Oct 17;20(20):5139. doi: 10.3390/ijms20205139.
4
The effects of nanocurcumin on Treg cell responses and treatment of ankylosing spondylitis patients: A randomized, double-blind, placebo-controlled clinical trial.纳米姜黄素对调节性 T 细胞反应的影响及其治疗强直性脊柱炎患者的效果:一项随机、双盲、安慰剂对照临床试验。
J Cell Biochem. 2020 Jan;121(1):103-110. doi: 10.1002/jcb.28901. Epub 2019 May 9.
5
Safety and efficacy of curcumin versus diclofenac in knee osteoarthritis: a randomized open-label parallel-arm study.姜黄素与双氯芬酸治疗膝骨关节炎的安全性和有效性:一项随机开放标签平行臂研究。
Trials. 2019 Apr 11;20(1):214. doi: 10.1186/s13063-019-3327-2.
6
Antineoplastic Actions of Cinnamic Acids and Their Dimers in Breast Cancer Cells: A Comparative Study.肉桂酸及其二聚体对乳腺癌细胞的抗肿瘤作用:一项比较研究。
Anticancer Res. 2018 Aug;38(8):4469-4474. doi: 10.21873/anticanres.12749.
7
Ferulic acid dimer as a non-opioid therapeutic for acute pain.阿魏酸二聚体作为一种用于急性疼痛的非阿片类治疗药物。
J Pain Res. 2018 Jun 6;11:1075-1085. doi: 10.2147/JPR.S161161. eCollection 2018.
8
An Intestinal "Transformers"-like Nanocarrier System for Enhancing the Oral Bioavailability of Poorly Water-Soluble Drugs.一种肠道“变形金刚”样的纳米载体系统,用于提高难溶性药物的口服生物利用度。
ACS Nano. 2018 Jul 24;12(7):6389-6397. doi: 10.1021/acsnano.8b00470. Epub 2018 Jun 6.
9
Pharmacology of Adenosine Receptors: The State of the Art.腺苷受体药理学:最新进展。
Physiol Rev. 2018 Jul 1;98(3):1591-1625. doi: 10.1152/physrev.00049.2017.
10
Sustained reversal of central neuropathic pain induced by a single intrathecal injection of adenosine A receptor agonists.单次鞘内注射腺苷 A 受体激动剂可持久逆转中枢神经性疼痛。
Brain Behav Immun. 2018 Mar;69:470-479. doi: 10.1016/j.bbi.2018.01.005. Epub 2018 Jan 31.